Laura Akullian D'agostino
About Laura Akullian D'agostino
Current Positions
Laura Akullian D'agostino is currently serving as the Vice President of Chemistry at Dunad Therapeutics in Cambridge, Massachusetts. Additionally, she also holds the position of Director of Small Molecule Drug Discovery at Bristol Myers Squibb, also located in Cambridge, Massachusetts.
Past Roles in Chemistry and Drug Discovery
Laura has extensive experience in chemistry and small molecule drug discovery through her various roles over the past 15 years. Notably, she was Director of Chemistry at Celgene for a month in 2019 and Associate Director of Chemistry from 2017 to 2019. Between 2012 and 2017, she also contributed as a Principal Scientist in Chemistry at Celgene. Preceding this, Laura worked at Avila Therapeutics, initially as a Senior Scientist from 2009 to 2011 and later as Principal Scientist for a brief period in 2012. Earlier roles include being a Senior Scientist and Scientist in Chemistry at Mersana Therapeutics from 2006 to 2009.
Educational Background in Chemistry
Laura Akullian D'agostino earned her Ph.D. in Organic Chemistry from Boston College, showcasing her strong foundational knowledge and expertise in chemistry. Prior to this, she completed her B.S. in Chemistry at the State University of New York at Oswego.
Expertise in Small Molecule Drug Discovery
With a career spanning over 15 years, Laura specializes in small molecule drug discovery and development. This expertise is reflected in her leadership roles across various biotech companies where she has contributed to the development of several drug candidates.
Track Record of Leadership
Laura has a proven track record of leading chemistry teams to successful project completions. She has been involved in strategic planning and execution of chemistry research programs, leveraging her background in organic chemistry and her focus on drug discovery.